The Population Screening Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Population Screening Market:
https://www.thebusinessresearchcompany.com/report/population-screening-global-market-report
According to The Business Research Company’s Population Screening Global Market Report 2024, The population screening market size has grown strongly in recent years. It will grow from $27.02 billion in 2023 to $29.12 billion in 2024 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to disease prevention initiative, government health policies, rising healthcare costs, increased disease awareness.
The population screening market size is expected to see strong growth in the next few years. It will grow to $37.93 billion in 2028 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to shift towards personalized medicine, aging population and chronic diseases, integration of ai and data analytics, expansion of screening access. Major trends in the forecast period include advancements in medical technology, genomics and precision screening, telehealth and remote screening, multi-disease screening panels, health equity and accessibility, .
The rising prevalence of cancer is expected to propel the growth of the population screening market going forward. Cancer is a condition in which specific cells in the human body develop inappropriately and spread to other parts of the human organism. Population screening can help detect cancer early when it is more treatable and has a better prognosis. For instance, according to the American Cancer Society, a US-based voluntary health organization, around 1.96 million new cancer cases are expected to be diagnosed in the US in 2023, an increase from approximately 1.9 million new cases that occurred in 2021. Therefore, the rising prevalence of cancer is driving the growth of the population screening market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=12587&type=smp
The population screening market covered in this report is segmented –
1) By Product: Hardware Equipment, Testing Or Lab, Analytics Or Interpretation
2) By Gender: Male, Female
3) By Age: Ages Less Than 15, 15-65, Ages 65 And Above
4) By Business: Hospitals, Research Institutes, Diagnostic Labs
Technological advancements are the key trend gaining popularity in the population screening market. Major companies operating in the population screening market are adopting new technologies to sustain their position in the market. For instance, in May 2021, Evoq Technologies LLC, a US-based company developing innovative technologies for healthcare and biotechnology research, launched SmartERG, the first phone-based retinal health testing platform. This device works to gather data about retinal health by flashing a regulated light at the eye and collecting an electrical and physiological response from the retina. Based on a delay or reduction in visual responses, it can identify retinal diseases that may develop to cause vision loss or blindness. It provides cloud services with strong AI (artificial intelligence) and machine learning support, easy patient-provider linkages, and ophthalmic care.
The population screening market report table of contents includes:
1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
Major Players:
- F. Hoffmann-La Roche Ltd.
- Thermo Fisher Scientific Inc.
- Abbott Laboratories
- Siemens Healthineers AG
- Quest Diagnostics Incorporated
Related Reports:
https://goodprnews.com/scuba-diving-equipment-market-share-and-current-insights/
https://goodprnews.com/thin-boiling-starch-market-growth/
https://goodprnews.com/vehicle-conversion-market-analysis-trends-and-forecast/
https://topprnews.com/scuba-diving-equipment-market-statistics-forecast/
https://topprnews.com/thin-boiling-starch-market-sales-consumption-demand/
https://topprnews.com/vehicle-conversion-market-size-share-revenue-trends/
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
